formaldehyde has been researched along with tamoxifen in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Andersen, J; Christensen, I; Poulsen, HS; Rasmussen, BB; Rose, C; Thorpe, SM | 1 |
| Bell, J; Blamey, RW; Cannon, P; Elston, CW; Goulding, H; Nicholson, R; Pearson, D; Pinder, S; Robertson, JF; Snead, D | 1 |
| Bottone, MG; Danova, M; Mangiarotti, R; Pellicciari, C; Wang, E | 1 |
| Burke, PJ; Koch, TH | 1 |
| Burke, PJ; Kalet, BT; Koch, TH | 1 |
| Barr, GA; Festa, ED; Inturrisi, CE; Jenab, S; Kuba, T; Nazarian, A; Quinones-Jenab, V; Wu, HB | 1 |
| Inturrisi, CE; Mannino, CA; Quinones-Jenab, V; South, SM | 1 |
| Desmedt, C; Durbecq, V; Foekens, JA; Haibe-Kains, B; Harris, AL; Larsimont, D; Piccart, M; Rouas, G; Sieuwerts, AM; Sotiriou, C; Toussaint, J | 1 |
| Kangarloo, SB; Konno, M; Magliocco, AM; Ng, ES; Paterson, A | 1 |
| Ahn, S; Jung, D; Kim, S; Lee, D; Lee, H; Park, KH; Park, S; Wang, HY | 1 |
| Ames, MM; Brauch, HB; Burgues, O; Chen, D; Cox, NJ; Goetz, MP; Gomez, HL; Gonzalez-Angulo, AM; Ingle, JN; Kalari, KR; Kuffel, MJ; Miller, VA; Nakamura, Y; Perou, CM; Ratain, MJ; Ross, JS; Safgren, SL; Silva, GO; Stephens, PJ; Suman, VJ; Sun, JX; Yelensky, R | 1 |
| Hamadeh, IS; Johnson, JA; Langaee, TY | 1 |
13 other study(ies) available for formaldehyde and tamoxifen
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Estrogen receptor in primary breast cancer estimated in paraffin-embedded tissue. A study of its usefulness compared to dextran-coated charcoal assay.
Topics: Breast Neoplasms; Female; Formaldehyde; Humans; Menopause; Paraffin Embedding; Prognosis; Receptors, Estrogen; Sensitivity and Specificity; Tamoxifen | 1991 |
A new immunohistochemical antibody for the assessment of estrogen receptor status on routine formalin-fixed tissue samples.
Topics: Adult; Aged; Antibodies, Monoclonal; Breast Neoplasms; Female; Formaldehyde; Humans; Immunohistochemistry; Middle Aged; Receptors, Estrogen; Sensitivity and Specificity; Tamoxifen; Tissue Fixation | 1995 |
Identification of resting cells by dual-parameter flow cytometry of statin expression and DNA content.
Topics: 3T3 Cells; Animals; Antigens, Neoplasm; Apoptosis; Biomarkers; Breast Neoplasms; Bromodeoxyuridine; Cell Cycle Proteins; Cell Division; Cell Line, Transformed; DNA, Neoplasm; Estrogen Antagonists; Estrogens; Female; Fixatives; Flow Cytometry; Fluorescent Antibody Technique; Formaldehyde; Gene Expression; Glioma; Humans; Ki-67 Antigen; Mice; Neoplasm Proteins; Nuclear Proteins; Polymers; Proliferating Cell Nuclear Antigen; Propidium; Proteins; Rats; Resting Phase, Cell Cycle; Tamoxifen; Thymus Gland | 1995 |
Design, synthesis, and biological evaluation of doxorubicin-formaldehyde conjugates targeted to breast cancer cells.
Topics: Antineoplastic Agents; Binding, Competitive; Breast Neoplasms; Cell Division; Cell Line; Cell Line, Tumor; Doxorubicin; Drug Design; Drug Screening Assays, Antitumor; Drug Stability; Estrogen Receptor Modulators; Female; Formaldehyde; Humans; Hydrolysis; Models, Molecular; Polyethylene Glycols; Receptors, Estrogen; Stereoisomerism; Structure-Activity Relationship; Tamoxifen | 2004 |
Antiestrogen binding site and estrogen receptor mediate uptake and distribution of 4-hydroxytamoxifen-targeted doxorubicin-formaldehyde conjugate in breast cancer cells.
Topics: Antineoplastic Agents; Binding Sites; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Female; Formaldehyde; Humans; Microscopy, Fluorescence; Receptors, Drug; Receptors, Estrogen; Structure-Activity Relationship; Tamoxifen | 2004 |
Estradiol and progesterone differentially regulate formalin-induced nociception in ovariectomized female rats.
Topics: Analgesia; Analysis of Variance; Animals; Estradiol; Estrogen Antagonists; Female; Formaldehyde; Ovariectomy; Pain; Pain Threshold; Progesterone; Rats; Rats, Sprague-Dawley; Statistics, Nonparametric; Tamoxifen | 2006 |
Estradiol replacement in ovariectomized rats is antihyperalgesic in the formalin test.
Topics: Animals; Behavior, Animal; Central Nervous System; Corticosterone; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrous Cycle; Female; Formaldehyde; Hormone Replacement Therapy; Hyperalgesia; Nociceptors; Ovariectomy; Pain Measurement; Peripheral Nervous System; Progesterone; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Tamoxifen; Vagina | 2007 |
Improvement of the clinical applicability of the Genomic Grade Index through a qRT-PCR test performed on frozen and formalin-fixed paraffin-embedded tissues.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Formaldehyde; Frozen Sections; Genes, Neoplasm; Humans; Middle Aged; Oligonucleotide Array Sequence Analysis; Paraffin Embedding; Predictive Value of Tests; Prognosis; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Survival Analysis; Tamoxifen | 2009 |
Extraction of tamoxifen and its metabolites from formalin-fixed, paraffin-embedded tissues: an innovative quantitation method using liquid chromatography and tandem mass spectrometry.
Topics: Breast Neoplasms; Chromatography, Liquid; Female; Formaldehyde; Humans; Neoplasm Recurrence, Local; Paraffin; Pilot Projects; Retrospective Studies; Tamoxifen; Tandem Mass Spectrometry | 2014 |
Evaluation of BrightGen HR RT-qDx assay to detect nuclear receptors mRNA overexpression in FFPE breast cancer tissue samples for selection of tamoxifen therapy.
Topics: Area Under Curve; Biomarkers, Tumor; Breast Neoplasms; Estrogen Antagonists; Female; Fixatives; Formaldehyde; Humans; Immunohistochemistry; Likelihood Functions; MCF-7 Cells; Paraffin Embedding; Patient Selection; Precision Medicine; Predictive Value of Tests; Prognosis; Real-Time Polymerase Chain Reaction; Receptors, Estrogen; Receptors, Progesterone; RNA, Messenger; ROC Curve; Tamoxifen; Tissue Fixation | 2014 |
Loss of heterozygosity at the CYP2D6 locus in breast cancer: implications for germline pharmacogenetic studies.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Breast Neoplasms; Cytochrome P-450 CYP2D6; Disease-Free Survival; DNA, Neoplasm; Female; Formaldehyde; Genotype; Humans; Loss of Heterozygosity; Middle Aged; Mouth Mucosa; Paraffin Embedding; Receptor, ErbB-2; Receptors, Estrogen; Survival Analysis; Tamoxifen; Tissue Fixation | 2014 |
Loss of heterozygosity at the CYP2D6 locus in breast cancer: implications for tamoxifen pharmacogenetic studies.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cytochrome P-450 CYP2D6; Drug Administration Schedule; Female; Formaldehyde; Genotype; Humans; Loss of Heterozygosity; Middle Aged; Paraffin Embedding; Primary Prevention; Selective Estrogen Receptor Modulators; Tamoxifen; Tissue Fixation | 2015 |